false
OasisLMS
Catalog
SCCM Resource Library
Pro: Corticosteroids Should Be Used for Most Patie ...
Pro: Corticosteroids Should Be Used for Most Patients With ARDS or Severe Pneumonia
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this pro-con debate on the use of corticosteroids for treating community-acquired pneumonia (CAP) and acute respiratory distress syndrome (ARDS), the speaker presents the case for corticosteroids in specific scenarios. The speaker emphasizes the importance of distinguishing between severe CAP and ARDS due to different responses to treatment. While there is some biological rationale for using corticosteroids, especially in severe CAP cases, the evidence base supporting their efficacy is often weak and varies across studies. Recent trials and guidelines suggest potential benefits in severe CAP with a shock component, highlighting hydrocortisone's effectiveness. However, high-dose corticosteroids like dexamethasone may not yield the same results for ARDS. Despite systematic reviews indicating possible mortality benefits, issues with extrapolation, inconsistent dosing regimens, and mixed trial results suggest caution in generalizing findings. The speaker concludes that separating severe CAP and ARDS for corticosteroid treatment consideration is crucial, as current guidelines offer only conditional recommendations.
Asset Caption
One-Hour Concurrent Session | Pro/Con Debate: How I Use Corticosteroids for ARDS and Pneumonia
Meta Tag
Content Type
Presentation
Membership Level
Professional
Membership Level
Select
Year
2024
Keywords
corticosteroids
community-acquired pneumonia
acute respiratory distress syndrome
hydrocortisone
treatment guidelines
mortality benefits
×
Please select your language
1
English